Admedus Limited Buy or Sell Recommendation

Macroaxis provides Admedus Limited buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Admedus Limited positions. The advice algorithm takes into account all of Admedus Limited available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Admedus Limited buy-and-hold prospective. Check also Admedus Limited Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Investment Horizon

  

Risk Tolerance

  
Symbol
Execute Advice
Admedus Limited -- USA Stock  

USD 0.196  0.004  2%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Admedus Limited is 'Strong Sell'.
For the selected time horizon Admedus Limited has a mean deviation of 1.11, semi deviation of 0.0, standard deviation of 2.11, variance of 4.44, downside variance of 0.0 and semi variance of 0.0
We provide buy or sell advice to complement the prevailing expert consensus on Admedus Limited. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available at the time. To make sure Admedus Limited is not overpriced, please confirm all Admedus Limited fundamentals including its Revenue, Cash Flow from Operations, Current Asset, as well as the relationship between Cash and Equivalents and Market Capitalization . As Admedus Limited appears to be a penny stock we also recommend to validate its Price to Book numbers.

Returns Distribution Density

Mean Return-0.61Value At Risk-4.3478
Potential Upside0.0Standard Deviation2.1083
 Return Density 
      Distribution 

Admedus Limited Greeks

α
Alpha over DOW
=(0.97) 
βBeta against DOW= 2.5 
σ
Overall volatility
= 2.08 
 IrInformation ratio =(0.36) 

Admedus Limited Volatility Alert

Admedus Limited exhibits very low volatility with skewness of -3.68 and kurtosis of 13.75. However, we advise investors to further study Admedus Limited technical indicators to make sure all market info is available and is reliable. Admedus Limited is a potential penny stock. Although Admedus Limited may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial stock hype. Please make sure you totally understand upside potential and downside risk of investing in Admedus Limited. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings,sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on this equity instrument if you perfectly time your entry and exit. However, remember that penny stocks that has been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The one and only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
    
 Better Than Average     
    
 Worse Than Average Compare Admedus Limited to competition
FundamentalsAdmedus LimitedPeer Average
Return On Equity(54.39) % (15.17) %
Return On Asset(36.19) % (15.64) %
Profit Margin(55.15) % (5.5) %
Operating Margin(71.79) % (10.91) %
Current Valuation110.69 M152.14 B
Price to Earning(3.06) times40.69 times
Price to Book2.2 times14.44 times
Price to Sales2.8 times17.81 times
Revenue17.97 M9.85 B
Gross Profit10 M21.75 B
EBITDA(11.41 M)1.41 B
Net Income(9.91 M)517.71 M
Cash and Equivalents9.06 M3.89 B
Cash per Share0.04 times5.17 times
Current Ratio7.36 times3.3 times
Book Value Per Share0.09 times13.64 times
Cash Flow from Operations(10.04 M)1.25 B
Earnings Per Share(0.06) times2.3 times
Number of Employees1210.67 K
Beta0.990.34
Market Capitalization50.36 M29.78 B
Total Asset27 M126.86 B
Retained Earnings(69 M)38.24 B
Working Capital13 M3.58 B
Current Asset17 M36.8 B
Current Liabilities4 M33.34 B
Z Score-2.8708.73
SellBuy
Strong Sell

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Currently Unavailable

Piotroski F Score

Financial Leverage

Inapplicable
Risk Adjusted Performance(0.066492)
Market Risk Adjusted Performance(0.24)
Mean Deviation1.11
Coefficient Of Variation(345.13)
Standard Deviation2.11
Variance4.44
Information Ratio(0.36)
Jensen Alpha(0.97)
Total Risk Alpha(1.76)
Treynor Ratio(0.25)
Maximum Drawdown9.09
Value At Risk(4.35)
Potential Upside0.0
Skewness(3.68)
Kurtosis13.75

Momentum

Admedus Limited Market Momentum